16 June 2020 : Clinical Research
Lower Platelet Aggregation Is a Risk Factor for Dual Antiplatelet Therapy-Associated Bleeding: A Preliminary Retrospective Study with Genotype Analysis
Dongdong Yuan1ABCD, Xiangfen Shi2BCD, Liping Guo1BF, Gaobiao Wang1BF, Yujie Zhao1B, Yuling Yang1B, Hanjuan Zhang1B, Qiong Huang1B, Yiqiang Yuan1AE*DOI: 10.12659/MSM.923758
Med Sci Monit 2020; 26:e923758
Table 3 Distribution of arachidonic acid-induced platelet aggregation rates in patients with reported bleeding events.
| ACA-induced platelet aggregation (%) | Patients (n=25) | % |
|---|---|---|
| 0–5 | 5 | 25% |
| 0–10 | 9 | 35% |
| 0–15 | 15 | 60% |
| 0–18 | 18 | 70% |
| 0–25 | 23 | 90% |
| 0–30 | 25 | 100% |
| ACA – arachidonic acid. | ||